Advancing Lung Imaging
with 129Xe MRI
Established in 2015, the Xe MRI Clinical Trials Consortium is a global cooperative network driving innovation in respiratory research and clinical trials. The Consortium consists of 14 clinical research centers with established hyperpolarized xenon in-vivo MRI capabilities and independent INDs (or equivalent) within North America and Europe.
What We Do
Identification of biomarkers for disease risk
Mechanisms for monitoring disease severity/activity
Development of image guided interventions
Tracking responses to treatment
Identification of clinical outcomes
Industry partnership for clinical trial innovation
Our Sponsors
By The Numbers
Quantifying the impact and reach of the Consortium
14
active member institutions
5
countries represented
2,800+
Xe MRI research scans completed since 2024
150,000+
combined respiratory patient population
